Dementia Drug Discovery Fund (worldwide)
The Dementia Discovery Fund (DDF) is a venture capital fund that invests in, and creates, new biotech companies to deliver high-impact therapeutics for age-related dementias. The Fund invests in drug discovery for all forms of dementia, including Alzheimer’s Disease (AD), Parkinson’s Disease Dementia (PDD), Frontotemporal Dementia (FTD), Amyotrophic Lateral Sclerosis (ALS), and Huntington’s Disease (HD). The Fund focuses on key areas where the underlying science is mature enough to support drug discovery and, with concentrated investment, has the potential to enable new therapeutic strategies. Researchers and innovators working on dementia drug discovery are encouraged to contact the Fund directly.
Create or sign in to your free account for more functionalities, including a full display of the eligibility criteria such as location and citizenship requirements.